American Journal of Roentgenology, Vol 163, 1459-1465, Copyright © 1994 by American Roentgen Ray Society

ARTICLES

Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F- fluorodeoxyglucose PET

D Kahn, KA Follett, DL Bushnell, MA Nathan, JG Piper, M Madsen and PT Kirchner
Department of Radiology, University of Iowa College of Medicine, Iowa City 52242.

OBJECTIVE. This prospective study was designed to compare the sensitivity and specificity of a relatively simple examination, 201Tl chloride single-photon emission CT (SPECT), with a more complex examination, 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET), in patients thought to have recurrent brain tumor. Because both agents have been shown to be markers of viable tumor, we hypothesized that their sensitivity and specificity should be the same. SUBJECTS AND METHODS. Nineteen patients with evidence of recurrent tumor on CT or MR images were studied with both 201Tl SPECT and FDG PET imaging. Two patients were examined twice, so a total of 21 studies were evaluated. The 201Tl SPECT and FDG PET examinations were performed on the same day in 17 patients, and the remaining four examinations were done within 1 week of one another. Three reviewers independently interpreted each Tl SPECT and PET scan. Inappropriate regional increases in 201Tl or FDG activity were considered indicative of tumor recurrence. Sensitivity and specificity values were based on biopsy results and clinical follow- up. The final diagnosis was tumor recurrence in 16 cases and radiation necrosis in 5 cases. The relationship of scan results to survival was analyzed. RESULTS. The sensitivity and specificity of the 201Tl examination for detecting tumor recurrence were 11 (69%) of 16 and two (40%) of five, respectively; values for the FDG PET examination were 13 (81%) of 16 and 2 (40%) of 5, respectively. In patients with recurrent tumors less than 1.6 cm in size, results were false-negative in four 201Tl SPECT examinations and three FDG PET studies. All tumor lesions 1.6 cm or larger (n = 8) were detected. Agreement among the three nuclear medicine specialists was complete for each of the 201Tl SPECT scans. There was disagreement on the interpretation of five (24%) of the 21 FDG PET scans, which was resolved by consensus. Scintigraphic findings did not correlate with patients' survival times. CONCLUSION. We were unable to detect a statistically significant difference in sensitivity or specificity between the 201Tl SPECT and FDG PET scans. Both techniques were sensitive for tumor recurrence with lesions less than 1.6 cm or larger. However, given the greater availability, simplicity, and ease of interpretation and the lower cost of the 201Tl SPECT studies, this technique should be considered for detection of tumor recurrence with lesions that are demonstrated to be 1.6 cm or larger on CT or MR examinations.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				L.S. Hu, L.C. Baxter, K.A. Smith, B.G. Feuerstein, J.P. Karis, J.M. Eschbacher, S.W. Coons, P. Nakaji, R.F. Yeh, J. Debbins, et al. Relative Cerebral Blood Volume Values to Differentiate High-Grade Glioma Recurrence from Posttreatment Radiation Effect: Direct Correlation between Image-Guided Tissue Histopathology and Localized Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging Measurements AJNR Am. J. Neuroradiol., March 1, 2009; 30(3): 552 - 558. [Abstract] [Full Text] [PDF]

				R.F. Barajas, J.S. Chang, P.K. Sneed, M.R. Segal, M.W. McDermott, and S. Cha Distinguishing Recurrent Intra-Axial Metastatic Tumor from Radiation Necrosis Following Gamma Knife Radiosurgery Using Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging AJNR Am. J. Neuroradiol., February 1, 2009; 30(2): 367 - 372. [Abstract] [Full Text] [PDF]

				Y. Terakawa, N. Tsuyuguchi, Y. Iwai, K. Yamanaka, S. Higashiyama, T. Takami, and K. Ohata Diagnostic Accuracy of 11C-Methionine PET for Differentiation of Recurrent Brain Tumors from Radiation Necrosis After Radiotherapy J. Nucl. Med., May 1, 2008; 49(5): 694 - 699. [Abstract] [Full Text] [PDF]

				D. C. Hockaday, S. Shen, J. Fiveash, A. Raubitschek, D. Colcher, A. Liu, V. Alvarez, and A. N. Mamelak Imaging Glioma Extent with 131I-TM-601 J. Nucl. Med., April 1, 2005; 46(4): 580 - 586. [Abstract] [Full Text] [PDF]

				N. Spaeth, M. T. Wyss, B. Weber, S. Scheidegger, A. Lutz, J. Verwey, I. Radovanovic, J. Pahnke, D. Wild, G. Westera, et al. Uptake of 18F-Fluorocholine, 18F-Fluoroethyl-L-Tyrosine, and 18F-FDG in Acute Cerebral Radiation Injury in the Rat: Implications for Separation of Radiation Necrosis from Tumor Recurrence J. Nucl. Med., November 1, 2004; 45(11): 1931 - 1938. [Abstract] [Full Text] [PDF]

				P. Beauchesne, R. Pedeux, M. Boniol, and C. Soler 99mTc-Sestamibi Brain SPECT After Chemoradiotherapy Is Prognostic of Survival in Patients with High-Grade Glioma J. Nucl. Med., March 1, 2004; 45(3): 409 - 413. [Abstract] [Full Text]

				S. Chandra, G. W. Kabalka, D. R. Lorey II, D. R. Smith, and J. A. Coderre Imaging of Fluorine and Boron from Fluorinated Boronophenylalanine in the Same Cell at Organelle Resolution by Correlative Ion Microscopy and Confocal Laser Scanning Microscopy Clin. Cancer Res., August 1, 2002; 8(8): 2675 - 2683. [Abstract] [Full Text] [PDF]

				S. Samnick, J. B. Bader, D. Hellwig, J. R. Moringlane, C. Alexander, B. F.M. Romeike, W. Feiden, and C.-M. Kirsch Clinical Value of Iodine-123-Alpha-Methyl-L-Tyrosine Single-Photon Emission Tomography in the Differential Diagnosis of Recurrent Brain Tumor in Patients Pretreated for Glioma at Follow-Up J. Clin. Oncol., January 15, 2002; 20(2): 396 - 404. [Abstract] [Full Text] [PDF]

				S. S. Gambhir, J. Czernin, J. Schwimmer, D. H. S. Silverman, R. E. Coleman, and M. E. Phelps A Tabulated Summary of the FDG PET Literature J. Nucl. Med., May 1, 2001; 42(90050): 1S - 93. [Full Text] [PDF]

				T. Nakano, K. Asano, M. Tanaka, T. Takahashi, H. Miura, and S. Suzuki Use of 201Tl SPECT for Evaluation of Biologic Behavior in Pituitary Adenomas J. Nucl. Med., April 1, 2001; 42(4): 575 - 578. [Abstract] [Full Text]

				D. D. Langleben and G. M. Segall PET in Differentiation of Recurrent Brain Tumor from Radiation Injury J. Nucl. Med., November 1, 2000; 41(11): 1861 - 1867. [Abstract] [Full Text] [PDF]

				H. C. Roberts and W. P. Dillon MR Imaging of Brain Tumors: Toward Physiologic Imaging AJNR Am. J. Neuroradiol., October 1, 2000; 21(9): 1570 - 1571. [Full Text]

				V. F.-H. Chong, Y.-F. Fan, and S. K. Mukherji Radiation-Induced Temporal Lobe Changes: CT and MR Imaging Characteristics Am. J. Roentgenol., August 1, 2000; 175(2): 431 - 436. [Abstract] [Full Text] [PDF]

				H. C. Roberts, T. P. L. Roberts, R. C. Brasch, and W. P. Dillon Quantitative Measurement of Microvascular Permeability in Human Brain Tumors Achieved Using Dynamic Contrast-enhanced MR Imaging: Correlation with Histologic Grade AJNR Am. J. Neuroradiol., May 1, 2000; 21(5): 891 - 899. [Abstract] [Full Text]

				T. Sugahara, Y. Korogi, S. Tomiguchi, Y. Shigematsu, I. Ikushima, T. Kira, L. Liang, Y. Ushio, and M. Takahashi Posttherapeutic Intraaxial Brain Tumor: The Value of Perfusion-sensitive Contrast-enhanced MR Imaging for Differentiating Tumor Recurrence from Nonneoplastic Contrast-enhancing Tissue AJNR Am. J. Neuroradiol., May 1, 2000; 21(5): 901 - 909. [Abstract] [Full Text]

				P. E. Ricci, A. Pitt, P. J. Keller, S. W. Coons, and J. E. Heiserman Effect of Voxel Position on Single-Voxel MR Spectroscopy Findings AJNR Am. J. Neuroradiol., February 1, 2000; 21(2): 367 - 374. [Abstract] [Full Text]

				L. G. Strauss Positron Emission Tomography: Current Role for Diagnosis and Therapy Monitoring in Oncology Oncologist, December 1, 1997; 2(6): 381 - 388. [Abstract] [Full Text] [PDF]